Radiopharm Theranostics (RAD:AU) has announced RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202 Download the PDF here. This post appeared first on investingnews.com Prev Post 5 Biggest Blockchain ETFs in 2025 June 4, 2025 Next Post S&P 500 Bullish Patterns: Are Higher Highs Ahead? June 4, 2025 Related Posts Chris Marcus: Silver Supply Crunch Not Over, Price Path Clear Long Term November 13, 2025 Top 10 Gold-mining Companies November 13, 2025 Prismo Metals Announces Closing of Upsized Private Placement November 13, 2025